| 布地奈德福莫特罗吸入气雾剂(I) | Mylan Pharmaceuticals Inc. | 每瓶120揿，每揿含布地奈德91μg和富马酸福莫特罗(按(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄·2H₂O计)5.1μg，递送剂量为布地奈德80μg和富马酸福莫特罗(按(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄·2H₂O计)4.5μg | Kindeva Drug Delivery L.P. | 国药准字HJ20250038 | 2025-04-01 | 查看 |
| 布地奈德福莫特罗吸入气雾剂(II) | Mylan Pharmaceuticals Inc. | 每瓶120揿，每揿含布地奈德181μg和富马酸福莫特罗(按(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄·2H₂O计)5.1μg，递送剂量为布地奈德160μg和富马酸福莫特罗(按(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄·2H₂O计)4.5μg | Kindeva Drug Delivery L.P. | 国药准字HJ20250037 | 2025-04-01 | 查看 |
| 布地奈德鼻喷雾剂 | 台湾海默尼药业有限公司 TAIWAN HEMONY PHARMACEUTICAL CO., LTD | 6ml:7.68mg;64μg/喷 | SYNMOSA BIOPHARMA CORPORATION, SYNMOSA PLANT | 国药准字HC20191008 | 2024-05-28 | 查看 |
| 布地奈德鼻喷雾剂 | 台湾海默尼药业有限公司 TAIWAN HEMONY PHARMACEUTICAL CO., LTD | 6ml:7.68mg;64μg/喷 | SYNMOSA BIOPHARMA CORPORATION, SYNMOSA PLANT | 国药准字HC20181007 | 2024-05-28 | 查看 |
| 吸入用布地奈德混悬液 | AstraZeneca Pty Ltd | 2ml：1mg | AstraZeneca Pty Ltd | 国药准字HJ20140475 | 2023-11-30 | 查看 |
| 吸入用布地奈德混悬液 | AstraZeneca Pty Ltd | 2ml：0.5mg | AstraZeneca Pty Ltd | 国药准字HJ20140474 | 2023-11-30 | 查看 |
| 布地奈德福莫特罗吸入粉雾剂(I) | AstraZeneca AB | 每支60吸，每吸含布地奈德80μg和富马酸福莫特罗4.5μg | AstraZeneca AB | 国药准字HJ20140459 | 2024-02-23 | 查看 |
| 布地奈德鼻喷雾剂 | McNeil Sweden AB | 每瓶120喷,每喷含布地奈德64μg,药液浓度为1.28mg/ml | McNeil AB | 国药准字HJ20171312 | 2023-09-27 | 查看 |
| 布地奈德福莫特罗吸入粉雾剂(II) | AstraZeneca AB | 每支60吸，每吸含布地奈德160μg和富马酸福莫特罗4.5μg | AstraZeneca AB | 国药准字HJ20140458 | 2024-02-23 | 查看 |
| 布地奈德鼻喷雾剂 | McNeil Sweden AB | 每瓶120喷,每喷含布地奈德64μg,药液浓度为1.28mg/ml | McNeil AB | 国药准字HJ20171311 | 2023-09-27 | 查看 |
| 布地奈德福莫特罗吸入粉雾剂(II) | AstraZeneca AB | 每支120吸，每吸含布地奈德160μg和富马酸福莫特罗4.5μg | AstraZeneca AB | 国药准字HJ20140457 | 2024-02-23 | 查看 |
| 布地奈德鼻喷雾剂 | McNeil Sweden AB | 每瓶120喷,每喷含布地奈德32μg,药液浓度为0.64mg/ml | McNeil AB | 国药准字HJ20171310 | 2023-09-27 | 查看 |
| 布地奈德鼻喷雾剂 | McNeil Sweden AB | 每瓶120喷,每喷含布地奈德32μg,药液浓度为0.64mg/ml | McNeil AB | 国药准字HJ20171309 | 2023-09-27 | 查看 |
| 布地奈德吸入粉雾剂 | Orion Corporation | 每瓶含粉末2.5g，每克粉末含布地奈德25.7mg， 每瓶100吸，每吸含布地奈德400μg | Orion Corporation | 国药准字HJ20140422 | 2024-07-23 | 查看 |
| 布地奈德吸入粉雾剂 | Orion Corporation | 每瓶含粉末2.5g，每克粉末含布地奈德25.7mg，每瓶200吸，每吸含布地奈德200μg | Orion Corporation | 国药准字HJ20140421 | 2024-07-23 | 查看 |
| 布地奈德福莫特罗吸入气雾剂(III) | AstraZeneca Pharmaceuticals LP | 每瓶120揿，每揿含布地奈德185 μg和富马酸福莫特罗(以(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄计)5.5 μg，递送剂量为布地奈德160 μg和富马酸福莫特罗(以(C₁₉H₂₄N₂O₄)₂·C₄H₄O₄计)4.8 μg | AstraZeneca Dunkerque Production | 国药准字HJ20240069 | 2024-06-28 | 查看 |
| 布地奈德肠溶胶囊 | Everest Medicines (Singapore) Pte. Ltd. | 4mg | Patheon Pharmaceuticals Inc. | 国药准字HJ20230130 | 2023-11-21 | 查看 |
| 布地格福吸入气雾剂 | AstraZeneca AB | 每瓶120揿，每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg | ASTRAZENECA DUNKERQUE PRODUCTION | 国药准字HJ20190063 | 2024-09-02 | 查看 |
| 布地奈德福莫特罗吸入粉雾剂(II) | AstraZeneca AB | 每支60吸,每吸含布地奈德320μg和富马酸福莫特罗9.0μg | AstraZeneca AB | 国药准字HJ20160447 | 2021-03-19 | 查看 |
| 布地奈德吸入气雾剂 | Chiesi Farmaceutici S.p.A. | 每瓶200揿,每揿含布地奈德200μg | Chiesi Farmaceutici S.p.A. | H20120320 | 2020-02-13 | 查看 |
